← 產業報告目錄
Precision Diagnostics & Medicine Market Size, Share & Trends Analysis Report, By Type (Genetic, DTC and Others), By Indication (Diagnostic and Medicine), By End-user, By Product, By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-30頁數 180報告編號 INSIGHTACE-73b2e07a20
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Precision Diagnostics & Medicine Market worldwide was assessed at USD 138.4 Bn. Analysts project it will expand to USD 425.9 Bn by 2034, at a CAGR of 12.3% spanning 2025 to 2034.
The Precision Diagnostics & Medicine sector involves The rapidly developing discipline of precision diagnostics and medicine focuses on customising medical interventions and diagnostic processes to each patient's unique characteristics. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Precision Diagnostics & Medicine Market Snapshot
Chapter 4. Global Precision Diagnostics & Medicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Precision Diagnostics & Medicine Market Trends
4.10. Global Precision Diagnostics & Medicine Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Precision Diagnostics & Medicine Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
5.2.1. Precision Diagnostics
5.2.1.1. Genetic Testing
5.2.1.2. DTC Testing
5.2.1.3. Other Types
5.2.2. Precision Medicine
5.2.2.1. Monoclonal Antibodies
5.2.2.2. Inhibitor Drugs
5.2.2.3. Cell & Gene Therapies
5.2.2.4. Antiviral & Anti-Retroviral Drugs
5.2.2.5. Other Products
Chapter 6. Precision Diagnostics & Medicine Market Segmentation 2: Indication, Estimates & Trend Analysis
6.1. Market Share by Indication, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
6.2.1. Precision Diagnostics
6.2.1.1. Oncology
6.2.1.2. Neurology
6.2.1.3. Immunology
6.2.1.4. Other Diagnostic Indications
6.2.2. Precision Medicine
6.2.2.1. Oncology
6.2.2.2. Rare Diseases
6.2.2.3. Infectious Diseases
6.2.2.4. Hematological Disorders
6.2.2.5. Other Medicine Indications
Chapter 7. Precision Diagnostics & Medicine Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Clinical Laboratories
7.2.2. Hospitals
7.2.3. Home Care Settings
Chapter 8. Precision Diagnostics & Medicine Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. Global Precision Diagnostics & Medicine Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.2.3. North America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
8.2.4. North America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.3. Europe
8.3.1. Europe Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.3.3. Europe Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
8.3.4. Europe Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.4.3. Asia Pacific Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
8.4.4. Asia Pacific Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.5. Latin America
8.5.1. Latin America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.5.3. Latin America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
8.5.4. Latin America Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
8.6.3. Middle East & Africa Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
8.6.4. Middle East & Africa Precision Diagnostics & Medicine Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. F. Hoffmann-La Roche Ltd (Switzerland)
9.2.1.1. Business Overview
9.2.1.2. Key Offering/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Agilent Technologies, Inc. (US)
9.2.3. Thermo Fisher Scientific Inc. (US)
9.2.4. Myriad Genetics, Inc. (US)
9.2.5. Guardant Health (US)
9.2.6. Abbott (US)
9.2.7. Illumina, Inc. (US)
9.2.8. Danaher (US)
9.2.9. Exact Sciences Corporation (US)
9.2.10. Qiagen (Netherlands)
9.2.11. 23andME, INC. (US)
9.2.12. ARUP Laboratories. (US)
9.2.13. Devyser (Sweden)
9.2.14. Diasorin S.P.A. (Italy)
9.2.15. Tempus (US)
9.2.16. Pillar Biosciences Inc. (US)
9.2.17. Invivoscribe, Inc. (US)
9.2.18. NeuroCode (US)
9.2.19. C2N Diagnostics (US)
9.2.20. Trinity Biotech Plc. (Ireland)
9.2.21. Amoy Diagnostics Co., Ltd. (China)
9.2.22. Novartis AG (Switzerland)
9.2.23. Bristol-Myers Squibb Company (US)
9.2.24. Gilead Sciences, Inc (US)
9.2.25. AstraZeneca (UK)
9.2.26. AbbVie Inc. (US)
9.2.27. Eli Lilly and Company (US)
9.2.28. Pfizer Inc. (US)
9.2.29. GSK plc. (UK)
9.2.30. Sanofi (France)
9.2.31. Johnson & Johnson Services, Inc. (US)
9.2.32. Vertex Pharmaceuticals Incorporated (US)
9.2.33. Amgen Inc. (US)
9.2.34. Merck KGaA (Germany)
9.2.35. Sarepta Therapeutics, Inc. (US)
9.2.36. Merck & Co., Inc.
9.2.37. Natera, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們